Related Experiment Video
Updated: May 17, 2025

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
Published on: November 18, 2018
Risk Factors for Adverse Outcomes in Connective Tissue Disease-Associated Pulmonary Hypertension.
Gayane Matusov1, Maryam Shams2, Karim Ibrahim3
1Department of Internal Medicine, Scripps Clinic, La Jolla, CA 92037, USA.
Pulmonary hypertension (PH) associated with connective tissue disease (CTD) significantly worsens patient outcomes. Early diagnosis and understanding risk factors are crucial for managing this rare, life-threatening condition in CTD patients.
Area of Science:
- Cardiology
- Rheumatology
- Pulmonology
Background:
- Pulmonary hypertension (PH) is a severe complication of connective tissue diseases (CTD).
- The prevalence and risk factors for PH in CTD vary significantly across different CTD subtypes.
- PH is a major determinant of poor prognosis in patients with CTD.
Purpose of the Study:
- To review the literature on PH in major CTDs, including systemic sclerosis and systemic lupus erythematosus.
- To summarize risk factors for developing PH and adverse outcomes in CTD-PH patients.
- To provide clinicians with a practical overview of CTD-PH for early diagnosis and management.
Main Methods:
- Systematic review of published literature on PH in CTD.
- Analysis of risk factors for PH development and mortality in CTD-PH.
- Synthesis of information on specific CTDs like systemic sclerosis and lupus erythematosus.
Main Results:
- Certain CTD manifestations are strongly associated with PH development.
- PH is a significant driver of adverse outcomes and mortality in CTD patients.
- Overlap syndromes involving PH and CTD impact patient prognosis.
Conclusions:
- Early detection of PH in CTD patients is essential for improving outcomes.
- Understanding specific risk factors for PH in different CTDs is critical for targeted screening.
- Effective management of CTD-PH requires a comprehensive approach considering disease-specific factors and PH overlap syndromes.
More Related Videos
07:41A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats
Published on: March 1, 2022
07:45Harvest of Endothelial Cells from the Balloon Tips of Swan-Ganz Catheters after Right Heart Catheterization
Published on: January 23, 2019
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...